Benefits of MELARIS® Testing

For patients with a p16 gene mutation, the result of the MELARIS test enables the development of a patient-specific medical management plan to significantly reduce the risk of cancer.  A positive result with MELARIS will allow you to:

  • Target screening and surveillance specifically to individuals with a p16 gene mutation€”maximizing patient care and increasing clinical efficiency
  • Improve patient compliance with tailored screening recommendations and preventive measures
  • Improve outcomes through prevention, earlier diagnosis and treatment of cancer, should it develop
  • Counsel patients and their family members on the underlying cause of the pattern of melanoma and possibly pancreatic cancer
  • Avoid unnecessary interventions for family members who do not test positive for the mutation known to be in the family